Skip to main content
Premium Trial:

Request an Annual Quote

Sigma and Ingex to Develop Prokaryotic Gene-Disruption System

NEW YORK, Oct. 14 (GenomeWeb News) - Germany-based Sigma-Aldrich and St. Louis, Mo.-based Ingex will collaborate in the development of a "novel" targeted prokaryotic gene-disruption technology, Sigma said yesterday in a statement.


The companies' TargeTron technology involves targeted insertion of a "TargeTron group II" intron into a host genome, resulting in "permanent" target gene knockout into a variety of prokaryotic genomes, said the statement. Targeted insertion is "more than 90 percent successful" and will work "across a broad range" of prokaryotes, the company added.


Future systems are planned for targeted plant and mammalian gene disruption, Sigma said.


The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.